Spironolactone may reduce the risk of incident rosacea

J Invest Dermatol. 2013 Oct;133(10):2480-2483. doi: 10.1038/jid.2013.186. Epub 2013 Apr 17.

¹ Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
² Galderma Research and Development, Sophia Antipolis, France.
³ Boston Collaborative Drug Surveillance Program, Boston University, Lexington, Massachusetts, USA.
⁴ Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland; Boston Collaborative Drug Surveillance Program, Boston University, Lexington, Massachusetts, USA. Electronic address: [email protected].

No abstract available

Publication types